Aprogen Biologics Inc. (KRX:003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
659.00
+19.00 (2.97%)
At close: Jul 17, 2025, 3:30 PM KST

Aprogen Biologics Company Description

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea.

It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss.

It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics.

Aprogen Biologics Inc. was founded in 1960 and is headquartered in Seongnam-si, South Korea.

Aprogen Biologics Inc.
CountrySouth Korea
Founded1960
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees377
CEOJeong-Chool Kim

Contact Details

Address:
Halla Sigma Valley 442-2
Seongnam-si
South Korea
Phone82 2 561 4011
Websiteen.aprogen-pharm.com

Stock Details

Ticker Symbol003060
ExchangeKorea Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7003060001
SIC Code2834

Key Executives

NamePosition
Jeong-Chool KimChief Executive Officer
Jung-Chul KimPresident